Business Context and Reporting Period
This Form 8-K is filed by OncoGenex Pharmaceuticals, Inc. (noted as "ACHIEVE LIFE SCIENCES, INC." in metadata, but the filing text identifies OncoGenex) on November 5, 2009. The report discloses the issuance of a press release regarding financial results for the quarter ended September 30, 2009.
Key Financial Metrics
The filing text serves as a notification of a press release (Exhibit 99.1) and does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The actual financial data is contained within the attached press release, which is incorporated by reference but not detailed in this document text.
Material Changes
The filing does not contain specific data to compare against prior periods. It only confirms that results for the quarter ended September 30, 2009, were announced.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It explicitly states that the attached press release is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934.
Investor Verification Checklist
- Verify the discrepancy between the metadata company name ("ACHIEVE LIFE SCIENCES, INC.") and the registrant name in the filing ("ONCOGENEX PHARMACEUTICALS, INC.").
- Review Exhibit 99.1 (the press release) to obtain actual financial figures for the quarter ended September 30, 2009.
- Confirm the current corporate status and name of the registrant, as the metadata suggests a potential name change or data mismatch.